chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Blood iron, Iron deficiency
Clinical narrative: Iron deficiency on 12Apr2021; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A 54 year-old female patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Lot number: EP7534) at the age of 54 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Blood pressure" (unspecified if ongoing), notes: Additional Information for Other Conditions: I take Blood pressure pills. Concomitant medication(s) included: VITAMIN D [VITAMIN D NOS]; VITAMIN B12 [VITAMIN B12 NOS]. The following information was reported: IRON DEFICIENCY (non-serious) with onset 12Apr2021, outcome "unknown", described as "Iron deficiency on 12Apr2021". Relevant laboratory tests and procedures are available in the appropriate section.  Additional Information: Patient missed her 2nd dose scheduled last April 22 and she is calling to make a schedule again but in a different facility or location. Patient 1st dose was given April 1. When probed for concern, patient stated, she was supposed to go and get second dose on the 22nd and she miss that appointment, so patient want to know if she can go to another location or what do I need to do. Patient stated she thought that's she was calling pfizer for to see where she can get her second shot patient already talked to one person.  No follow-up attempts are possible. No further information is expected.  Follow up (24Apr2021): The initial case was missing the following minimum criteria: No adverse event. Upon receipt of follow-up information on (24Apr2021), this case now contains all required information to be considered valid.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Skin disorder
Clinical narrative: Bumps started showing five days after first shot; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 02Apr2021 13:45 (Lot number: ER8732) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Chronic Mononucleosis" (unspecified if ongoing); "Chronic Fatigue" (unspecified if ongoing); "Chronic Migranes" (unspecified if ongoing). Concomitant medication(s) included: BUPROPION; RALOXIFENE; BIESTROGEN; CASCARA SAGRADA [RHAMNUS PURSHIANA BARK]. Past drug history included: Ibuprofen, reaction(s): "Known allergies: Ibuprofen". The following information was reported: SKIN DISORDER (non-serious) with onset 07Apr2021, outcome "unknown", described as "Bumps started showing five days after first shot". The event "bumps started showing five days after first shot" was evaluated at the physician office visit. Therapeutic measures were taken as a result of skin disorder.  If other vaccine in four weeks-No. Prednisone and Zyrtec were used for treatment. If covid prior vaccination-No. If covid tested post vaccination-No  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Chills, Headache, Pain
Clinical narrative: experienced headache, chills and body sore; experienced headache, chills and body sore; experienced headache, chills and body sore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 23Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), CHILLS (non-serious), PAIN (non-serious), outcome "unknown" and all described as "experienced headache, chills and body sore".  Additional Information: Got the first dose last 23Apr and the second dose is on 18May. After the first dose he experienced headache, chills and body sore. He was asking if it is okay to take Tylenol for the pain reliever.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Illness, Myalgia, Pain in extremity
Clinical narrative: is sick; arm and muscle is hurt; arm and muscle is hurt; This is a spontaneous report received from a contactable reporter (Consumer).  A 20 year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 15Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious) with onset Apr2021, outcome "unknown", described as "is sick"; PAIN IN EXTREMITY (non-serious), MYALGIA (non-serious) all with onset Apr2021, outcome "unknown" and all described as "arm and muscle is hurt".  Additional information: Caller was calling on behalf of her grandson, 20 years old. She said that her grandson got the first dose last Thursday April 15. This whole week, her grandson was sick (arm and muscle was hurt).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site joint movement impairment, Vaccination site pain
Clinical narrative: got very sore reaction from the vaccine/it hurts a lot; got very sore reaction from the vaccine/it hurts a lot; She cannot put her arm by her ear without excruciating pain; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "got very sore reaction from the vaccine/it hurts a lot"; VACCINATION SITE JOINT MOVEMENT IMPAIRMENT (non-serious), outcome "unknown", described as "She cannot put her arm by her ear without excruciating pain".  Additional information: Patient got very sore reaction from the vaccine. She mentions that it hurts a lot. She cannot put her arm by her ear without excruciating pain. She is wondering if she needs to put a cold pack or a warm pack. Patient was wondering if she can go get Botox (Dysport) on her face, does it have a contraindication with he vaccine, does she have to wait some days and asking information regarding the use of the Pfizer-BioNTech COVID-19 Vaccine in people who have cosmetic fillers or Botox.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: Caller mentioned her husband was not feeling well initially; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "Caller mentioned her husband was not feeling well initially".  Additional information:Reporter stated if it would be okay to get the second dose, will it be worse on the 2nd dose. Reporter stated mentioned her husband was not feeling well initially, and afterwards, started to feel bad also.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Circumstance or information capable of leading to medication error, Fatigue, Headache, Pain in extremity
Clinical narrative: she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.; Her leg has been hurting from the knee down and also her arm is aching a little,; She was feeling extremely tired; She had a really bad headache; Sinus problems; Her leg has been hurting from the knee down and also her arm is aching a little,; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 07Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Leg problems" (unspecified if ongoing), notes: She said she had leg problems before getting her first shot. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "unknown", described as "She was feeling extremely tired"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "She had a really bad headache"; SINUS DISORDER (non-serious) with onset Apr2021, outcome "unknown", described as "Sinus problems"; ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset Apr2021, outcome "unknown" and all described as "Her leg has been hurting from the knee down and also her arm is aching a little,"; CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.".  Additional information: Caller received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 07Apr2021, for the next week she had a really bad headache but she was also dealing with sinus problems. Her leg had been hurting from the knee down and also her arm was aching a little, also she had been feeling extremely tired. She would like to know if she should receive the second dose of the vaccine, she was scheduled for the second dose tomorrow, because she did not get any medications and she did not want to get sick.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Sinus disorder
Clinical narrative: she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.; Her leg has been hurting from the knee down and also her arm is aching a little,; She was feeling extremely tired; She had a really bad headache; Sinus problems; Her leg has been hurting from the knee down and also her arm is aching a little,; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP).  A 73 year-old female patient received bnt162b2 (BNT162B2), administration date 07Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. Relevant medical history included: "Leg problems" (unspecified if ongoing), notes: She said she had leg problems before getting her first shot. The patient's concomitant medications were not reported. The following information was reported: FATIGUE (non-serious) with onset Apr2021, outcome "unknown", described as "She was feeling extremely tired"; HEADACHE (non-serious) with onset Apr2021, outcome "unknown", described as "She had a really bad headache"; SINUS DISORDER (non-serious) with onset Apr2021, outcome "unknown", described as "Sinus problems"; ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious) all with onset Apr2021, outcome "unknown" and all described as "Her leg has been hurting from the knee down and also her arm is aching a little,"; CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR (non-serious), outcome "unknown", described as "she's scheduled for the second dose tomorrow, because she doesn't get any medications and she doesn't want to get sick.".  Additional information: Caller received the first dose of the Pfizer-BioNtech Covid-19 vaccine on 07Apr2021, for the next week she had a really bad headache but she was also dealing with sinus problems. Her leg had been hurting from the knee down and also her arm was aching a little, also she had been feeling extremely tired. She would like to know if she should receive the second dose of the vaccine, she was scheduled for the second dose tomorrow, because she did not get any medications and she did not want to get sick.  No follow-up attempts are possible. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Keratosis pilaris, Lymphadenopathy
Clinical narrative: Swollen lymph nodes on the left side (which is the side he got his vaccine) and small bumps all around that area; Swollen lymph nodes on the left side (which is the side he got his vaccine) and small bumps all around that area; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious), KERATOSIS PILARIS (non-serious), outcome "not recovered" and all described as "Swollen lymph nodes on the left side (which is the side he got his vaccine) and small bumps all around that area".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache
Clinical narrative: Chills, headache experienced 1 day after vaccination; Chills, headache experienced 1 day after vaccination; This is a spontaneous report received from a contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 16-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: HEADACHE (non-serious), CHILLS (non-serious), outcome "unknown" and all described as "Chills, headache experienced 1 day after vaccination".  No follow-up attempts are possible. Information on lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Pain in extremity
Clinical narrative: Dizzy; sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIZZINESS (non-serious), outcome "recovered" (2021), described as "Dizzy"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "sore arm".  Additional Information: Reporter stated, his sister got the same shot the day before he did at the same place and she said hers made her feel dizzy for 2 days but that was her only reaction other than a sore arm. All he knew about his sister's experience was that, it made her dizzy. He stated that he was not able to answer all these questions for his sister's experience.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain
Clinical narrative: Mild nausea and body ache; Mild nausea and body ache; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from a sales representative.  A 57 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NAUSEA (non-serious), PAIN (non-serious), outcome "unknown" and all described as "Mild nausea and body ache".  Additional information: The patient had mild nausea and body ache one day after vaccination.Event took place after use of product.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Discomfort, Dizziness, Emotional disorder, Fatigue, Feeling drunk
Clinical narrative: Very dizzy; I felt an all over pressure in my whole body that made me feel like I was imploding; Felt drunk; felt very emotional; became exhausted/still tired; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 07Apr2021 12:00 (Lot number: ER8737) at the age of 55 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Connective tissue disorder" (unspecified if ongoing). There were no concomitant medications. The following information was reported: DIZZINESS (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "Very dizzy"; DISCOMFORT (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "I felt an all over pressure in my whole body that made me feel like I was imploding"; FEELING DRUNK (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "Felt drunk"; EMOTIONAL DISORDER (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "felt very emotional"; FATIGUE (non-serious) with onset 07Apr2021 12:00, outcome "not recovered", described as "became exhausted/still tired". Therapeutic measures were not taken as a result of dizziness, discomfort, feeling drunk, emotional disorder, fatigue.  Additional information: Vaccine facilitated type was workplace clinic. The patient had not received any other vaccines within 4 weeks, had not received any other medications in two weeks, Within 2-3 minutes of receiving the vaccine the patient became very dizzy. Her son received his first dose at the same time and reported the same symptom to her. No Covid prior to vaccination and had not tested covid post vaccination, Known allergies was sensitivities but don't know to what, this is making it more clear however.  No follow-up attempts are possible. No further information is expected.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 53 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 17Apr2021 11:00 (Lot number: ER8731) at the age of 53 years as dose 1, single for covid-19 immunisation. Relevant medical history included: "Fibromyalgia", start date: 2020 (ongoing); "osteoarthritis" (ongoing); "Rheumatoid arthritis", start date: Mar2021 (ongoing); "Migraines" (unspecified if ongoing); "Acid reflux", start date: 2020 (unspecified if ongoing); "inflammatory arthritis", start date: Mar2021 (ongoing); "COVID-19", start date: 2020 (unspecified if ongoing), notes: Verbatim: Caller reported that she had Oovid-19 last year in 2020. Concomitant medication(s) included: PREDNISONE taken for arthritis, start date: 27Mar2021, stop date: 17Apr2021; PREGABALIN;PF-00489791 taken for fibromyalgia, start date: May2020 (ongoing); PANTOPRAZOLE taken for gastrooesophageal reflux disease, start date: Aug2020 (ongoing); TOPIRAMATE taken for migraine, start date: Jun2020 (ongoing); PROPRANOLOL taken for tremor, migraine, start date: Nov2020 (ongoing); HYDROXYCHLOROQUINE, start date: Apr2021 (ongoing); DOXEPIN HYDROCHLORIDE taken for fibromyalgia, sleep disorder, sleep disorder, start date: Apr2021 (ongoing); DULOXETINE DR taken for fibromyalgia, start date: 2020 (ongoing); VITAMIN D3 taken for blood iron abnormal, start date: Apr2021 (ongoing); VITAMIN B12 & FOLIC ACID, start date: Dec2020. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 17Apr2021, outcome "recovering", described as "Sore arm".  Additional information:It was reported that she had previously taken Topiramate for migraines and stopped taking it when she had surgery because she didn't want to take a whole lot of medication. She took 4 tablets of prednisone, then 3 tablets, then 2 tablets, and then 1 tablet until the medication was completed. She was diagnosed with migraines, maybe 15 or 16 years ago. It might have been longer than 15 or 16 years since she was diagnosed with migraines. Patient did not required emergency room or physician office. No prior vaccination within 4 weeks.  No follow-up attempts are possible. No further information is expected.
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Paraesthesia
Clinical narrative: she has experienced paresthesia's/Tingling; numbness; weakness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 32 year-old female patient received bnt162b2 (BNT162B2), administration date 19Mar2021 (Batch/Lot number: unknown) at the age of 32 years as single dose for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PARAESTHESIA (non-serious), outcome "unknown", described as "she has experienced paresthesia's/Tingling"; HYPOAESTHESIA (non-serious), outcome "unknown", described as "numbness"; ASTHENIA (non-serious), outcome "unknown", described as "weakness".  Additional information: received the first dose of the Pfizer COVID vaccine on 19Mar2021. Patient reported that since then she has experienced paresthesia's, numbness, tingling, and weakness that has lasted the past five weeks.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: vertigo, everything is spinning; vertigo, everything is spinning; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Dose 1, Manufacturer unknown), for covid-19 immunization. The following information was reported: VERTIGO (non-serious), DIZZINESS (non-serious), outcome "unknown" and all described as "vertigo, everything is spinning".  Additional information: Report was not related to a study or programme. Caller stated that she had never been sick in her life, she takes no medications or nothing.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Blood glucose increased, Feeling abnormal, Nausea
Clinical narrative: My body felt like it was dipped in lead and that I was drugged; Felt very nauseous; blood sugars rocketed; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 61 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 23Apr2021 16:15 (Lot number: EW0175) at the age of 61 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "IDDM - type I" (unspecified if ongoing), notes: Other medical history: IDDM - type I. The patient took concomitant medications. Vaccination history included: Bnt162b2 (Dose number=1, Lot number: ER8737, Administration date= 02Apr2021, Administration time: 11:00 , Vaccine location= Right arm), administration date: 02Apr2021, when the patient was 61 years old, for Covid-19 immunisation. The following information was reported: FEELING ABNORMAL (non-serious) with onset 24Apr2021 06:00, outcome "recovered" (2021), described as "My body felt like it was dipped in lead and that I was drugged"; NAUSEA (non-serious) with onset 24Apr2021 06:00, outcome "recovered" (2021), described as "Felt very nauseous"; BLOOD GLUCOSE INCREASED (non-serious) with onset 24Apr2021 06:00, outcome "recovered" (2021), described as "blood sugars rocketed". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of feeling abnormal, nausea, blood glucose increased.   Additional information: The patient had no known allergies. The patient was not tested with Covid prior vaccination and post vaccination. The patient did not receive any other vaccine in four weeks and received other medications in two weeks. The patient drank about a gallon and a half of water those hours.   No follow-up attempts are possible. No further information is expected.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Joint swelling, Pain
Clinical narrative: left knee started to swell and hurt /knee swelling; an uncomfortable pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 31Mar2021 (Lot number: er8730, Expiration Date: 03Jul2021) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: JOINT SWELLING (non-serious), outcome "unknown", described as "left knee started to swell and hurt /knee swelling"; PAIN (non-serious), outcome "unknown", described as "an uncomfortable pain".  Additional information: Patient stated that she received her vaccination on 31Mar2021 and reported that "maybe 6-10 days afterwards my left knee started to swell and hurt, an uncomfortable pain", and reported that had no injury prior to that and the only thing she had done different was get the vaccine. Patient asked if the knee swelling she was experiencing after her vaccination was an autoimmune response or an orthopedic issues.  No follow-up attempts are possible. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: The caller states that she currently has a urinary tract infection and is taking an antibiotic to treat this infection; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 08Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: URINARY TRACT INFECTION (non-serious), outcome "unknown", described as "The caller states that she currently has a urinary tract infection and is taking an antibiotic to treat this infection". Therapeutic measures were taken as a result of urinary tract infection. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Myalgia
Clinical narrative: Mild fatigue and muscle ache lasting 2 days; Mild fatigue and muscle ache lasting 2 days; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 75 year-old female patient received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 14Apr2021 11:00 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Vaccination history included: Bnt162b2 (Intramuscularly in upper right arm at 11:30 as dose 1, single), administration date: 04Mar2021, when the patient was 75 years old, for COVID-19 immunisation, reaction(s): "tested positive for Covid-19". The following information was reported: FATIGUE (non-serious), MYALGIA (non-serious) all with onset Apr2021, outcome "recovered" (Apr2021) and all described as "Mild fatigue and muscle ache lasting 2 days".  Additional information: The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vascular rupture
Clinical narrative: prominent vessel rupture to her hand to fingers; other hand and very painful; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program.  A 47 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) at the age of 47 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: VASCULAR RUPTURE (non-serious), outcome "unknown", described as "prominent vessel rupture to her hand to fingers"; PAIN IN EXTREMITY (non-serious) with onset Apr2021, outcome "unknown", described as "other hand and very painful".  Additional information: 3 hours after vaccination, the patient had a prominent vessel rupture to her hand to fingers; 5 days ago, patient's other hand and it was very painful. Patient was asking if she should receive the second dose this evening (day of report).  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: sick; This is a spontaneous report received from contactable reporter(s) (Other HCP). A 59 year-old female patient received bnt162b2 (BNT162B2), administration date 2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. Relevant medical history included: "Rheumatoid arthritis" (unspecified if ongoing); "Covid", start date: Jan2021 (unspecified if ongoing). Concomitant medication(s) included: XELJANZ XR taken for rheumatoid arthritis (ongoing). Vaccination history included: Covid-19 vaccine (DOSE 1, MANUFACTURER UNKNOWN), for COVID-19 immunisation. The following information was reported: ILLNESS (non-serious) with onset 2021, outcome "unknown", described as "sick".  Additional details: Patient reports being off medication Jan2021 due to having covid. Patient stated that she was advised to start when all symptoms resolved. After symptoms resolved, patient received covid vaccine which she "got sick" from, and then recommendation was to pause therapy until 1 week after vaccination. Re-started Xeljanz after second vaccine was received, a couple of weeks ago as per patient.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness
Clinical narrative: noticed in the last 5-6 days a very stiff neck; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 58 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st dose), for COVID-19 immunization. The following information was reported: MUSCULOSKELETAL STIFFNESS (non-serious), outcome "unknown", described as "noticed in the last 5-6 days a very stiff neck".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain, Back pain, Chills, Nausea
Clinical narrative: back pain; arm is sore; chills; Nausea; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 23Feb2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious) with onset 2021, outcome "not recovered", described as "back pain"; AXILLARY PAIN (non-serious) with onset 2021, outcome "not recovered", described as "arm is sore"; CHILLS (non-serious) with onset 2021, outcome "not recovered", described as "chills"; NAUSEA (non-serious) with onset 2021, outcome "not recovered", described as "Nausea".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Migraine
Clinical narrative: Migraine; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MIGRAINE (non-serious), outcome "unknown", described as "Migraine". Therapeutic measures were taken as a result of migraine.  Additional information: Patient had taken tylenol for her migraine before the 2nd dose. Wanted to know what other pain relievers she can take because tylenol isn't effective.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: slight dizziness; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558). The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 15Mar2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st  dose), for Covid-19 immunization. The following information was reported: DIZZINESS (non-serious), outcome "unknown", described as "slight dizziness".  Additional information: Caller received second CoVax on 3/15/21 and not sure if it is interacting with Thyroid medication. She said experienced slight dizziness and asked if any other calls about same concern.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Loss of personal independence in daily activities
Clinical narrative: could not get out of bed the following morning; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 21Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious) with onset 24Apr2021, outcome "unknown", described as "could not get out of bed the following morning".  Additional information: The patient had the first shot of the vaccine on 21Apr2021, he had no problem. However on 23Apr2021, he went to bed at 11 o'clock and could not get out of bed the following morning 24Apr2021.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Hot flush, Nausea
Clinical narrative: he has been feeling fatigued/ tired; Hot and cold flashes; diarrhea; nausea; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 59 year-old male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2, when the patient was 59 years old, for COVID-19 Immunization. The following information was reported: FATIGUE (non-serious), outcome "unknown", described as "he has been feeling fatigued/ tired"; HOT FLUSH (non-serious), outcome "unknown", described as "Hot and cold flashes"; NAUSEA (non-serious) with onset 27Apr2021, outcome "not recovered", described as "nausea"; DIARRHOEA (non-serious), outcome "not recovered", described as "diarrhea".  Additional information: Caller stated he received the second dose of Pfizer's COVID vaccine on Sunday and ever since he has been feeling fatigued. Caller stated, "Yesterday, I tried to go to work and I experienced hot and cold flashes and nausea and diarrhea. I still have the nausea and diarrhea today, 27Apr2021. Is that normal Or should I go to the ER But I feel fine. I've been so tired it seems like I can't just stay up."  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Joint range of motion decreased, Pain in extremity
Clinical narrative: I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way; I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 25 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), JOINT RANGE OF MOTION DECREASED (non-serious), outcome "unknown" and all described as "I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way".  Additional Information: Reporter stated that she received the 1st dose about a month ago. "I am still in a lot of pain. It doesn't happen every day, but some days the pain is so bad, I can only lift my arm half way. I was getting ready to get the vaccine . I am not sure how to proceed, if I should delay or just go through with it. I am supposed  to get the vaccine today. I had a side effect after the first dose of the vaccine.  Should I get the second dose? PQC Present was reported as No.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This is a spontaneous report received from a contactable reporter(s) (Other HCP) from medical information team. The reporter is the parent and reported for a 27-year-old patient (reporter's daughter).  A 27 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "Sore arm".  Additional Information: My mom age 92 and brother got both doses of the Pfizer; none of them have allergies. My older daughter got both doses. My other daughter age: 27 received the first dose of the Pfizer got a sore arm. I was hesitant due to my allergies.    No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: got very sick; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ILLNESS (non-serious), outcome "unknown", described as "got very sick".  Additional information: It was reported as they would like to know how effective was the Pfizer Covid-19 vaccine with a single dose and if there were any bad effect if you do not complete the vaccination series. State that many people have been intentionally missing the second does because of the side effects they presented, including her brother. Stated his brother got very sick after the first dose.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: They got sick after first dose; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non-HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 06Apr2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported.  The following information was reported: ILLNESS (non-serious) with onset Apr2021, outcome "unknown", described as "They got sick after first dose".  Additional information: Reporter reported that reschedule appointment for second dose to 28Apr2021 per notice received from vaccination provider. Caller advised they "got sick" after first dose of vaccine 06Apr2021 and questioning whether or not to get second dose. Read FAQ. Declined transfer to Sheet/faxed for AE - side effects/second dose appointment beyond 21 days  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Blood test, Blood test abnormal, Dizziness, Euphoric mood
Clinical narrative: felt high and giddy; felt high and giddy; tested Positive for PCP in her blood test; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: EUPHORIC MOOD (non-serious), DIZZINESS (non-serious), outcome "unknown" and all described as "felt high and giddy"; BLOOD TEST ABNORMAL (non-serious), outcome "unknown", described as "tested Positive for PCP in her blood test". Relevant laboratory tests and procedures are available in the appropriate section.  Additional information: The patient mentioned that there might be a medication that can cause a false positive result for that according to her doctor.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Fatigue, Nausea
Clinical narrative: Nausea; Fatigue; Diarhea; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2), administration date 01Apr2021 (Batch/Lot number: unknown) as dose1,single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose of covid-19 vaccine.), administration date: 12Mar2021, for Covid-19 Immunization. The following information was reported: NAUSEA (non-serious) with onset 01Apr2021, outcome "unknown", described as "Nausea"; FATIGUE (non-serious) with onset 01Apr2021, outcome "unknown", described as "Fatigue"; DIARRHOEA (non-serious) with onset 01Apr2021, outcome "unknown", described as "Diarhea".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal
Clinical narrative: not feeling good; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FEELING ABNORMAL (non-serious), outcome "unknown", described as "not feeling good".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: Hearing is not very good; This is a spontaneous report from a contactable male consumer (patient) via a Pfizer sponsored program. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection; Lot number: unknown) in 27Jan2021 as a dose 1, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. On an unknown date, patient experienced "Hearing is not very good". Consumer stated that patient had received the first dose of the Pfizer Covid 19 vaccine on the 27Jan2021. For personal reasons was not able to receive second dose within the 42 days and at the time of report he was wondering if it was possible for him to receive the second dose. He was wondering what was the contraindication to receive the second dose after so much time passed from 27Jan. He was also wondering what was the efficacy or potency of having just received one shot of the vaccine. And he was wondering how long that potency lasts having received just one injection. While in conversation with Consumer stated that his hearing was not very good. The outcome for the event Hearing is not very good was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.  Follow up (26Apr2021): This is a follow up spontaneous report from a contactable consumer. This consumer (patient) suspect onset date and event were updated.  No follow up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19
Symptoms: Skin atrophy, Skin disorder
Clinical narrative: she has thin skin; Her skin pulled away from falling; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the parent.  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First dose), for Covid-19 Immunization. The following information was reported: SKIN ATROPHY (non-serious), outcome "unknown", described as "she has thin skin"; SKIN DISORDER (non-serious), outcome "unknown", described as "Her skin pulled away from falling".  Additional Information: Reporters mom would have her second dose of the vaccine and she had thin skin. Her skin pulled away from falling and wanted to know if she can still have her second dose of the vaccine. Read Privacy statement.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.